Every life sciences company knows that patient safety is non negotiable, but the way safety is managed—and the value ...

Artificial intelligence has moved from pilot projects to a central role in many life sciences strategies. What began as a set ...

Caris projects 2026 total revenue in the range of $1.0 billion to $1.02 billion, anticipating molecular profiling growth of approximately 21% to 22%, and therapy selection volume growth of around 20% ...

Caris Life Sciences Inc. CAI shares are up during Friday’s premarket session following better-than-expected fourth-quarter earnings and a significant interim readout from the company’s Achieve 1 study ...

A colorectal cancer blood test candidate from Exact Sciences fell short in its pivotal study, but the company is still in the hunt to provide an alternative to the liquid biopsy that was first to ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Joel Mokyr, Philippe Aghion and Peter Howitt have been awarded the 2025 Nobel Prize in Economics. (Photo by Jonathan Nackstrand / AFP) / ALTERNATIVE CROP (Photo by JONATHAN NACKSTRAND/AFP via Getty ...

Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after gaining 31 hedge fund ...